Earnings Call · Q4 FY2022·2023-03-23

Q4 22EPS -6.02%·Rev n/aQ3 22EPS +14.29%·Rev n/aQ2 22EPS +18.18%·Rev n/aQ1 22EPS -14.75%·Rev n/a⚠ consensus missing

RELMADA THERAPEUTICS, INC. RLMD

Tim McCarthy — Host

Sergio Traversa — Chief Executive Officer

Maged Shenouda — Chief Financial Officer

−0.9%1d on move date−1.1% vs SPY3d+1.3%5d+6.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RLMD calls or request research access.

More RLMD calls Browse calls Request research access